290 related articles for article (PubMed ID: 36530732)
1. Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.
Zhang W; Bai Y; Sun C; Lv Z; Wang S
Front Public Health; 2022; 10():1058722. PubMed ID: 36530732
[TBL] [Abstract][Full Text] [Related]
2. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
Sung H; Wiese D; Jatoi I; Jemal A
JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
[TBL] [Abstract][Full Text] [Related]
3. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
4. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
Scott LC; Mobley LR; Kuo TM; Il'yasova D
Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
[TBL] [Abstract][Full Text] [Related]
5. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
6. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage.
Du XL; Song L
Cancer Epidemiol; 2022 Feb; 76():102076. PubMed ID: 34861613
[TBL] [Abstract][Full Text] [Related]
8. Are There Regional Differences in Triple Negative Breast Cancer among Non-Hispanic Black Women?
Bartley SJ; Wu M; Benard V; Ambrosone C; Richardson LC
J Natl Med Assoc; 2021 Jun; 113(3):353-356. PubMed ID: 32778443
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
Yoo W; Kim S; Huh WK; Dilley S; Coughlin SS; Partridge EE; Chung Y; Dicks V; Lee JK; Bae S
PLoS One; 2017; 12(2):e0172548. PubMed ID: 28234949
[TBL] [Abstract][Full Text] [Related]
10. High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
Hercules SM; Hercules JC; Ansari A; Date SAJ; Skeete DHA; Smith Connell SP; Pond GR; Daniel JM
Cancer; 2020 May; 126(10):2217-2224. PubMed ID: 32154924
[TBL] [Abstract][Full Text] [Related]
11. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
12. Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.
Davis Lynn BC; Chernyavskiy P; Gierach GL; Rosenberg PS
J Natl Cancer Inst; 2022 Feb; 114(2):263-270. PubMed ID: 34508608
[TBL] [Abstract][Full Text] [Related]
13. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors.
Moss JL; Tatalovich Z; Zhu L; Morgan C; Cronin KA
Breast Cancer; 2021 Jan; 28(1):82-91. PubMed ID: 32671723
[TBL] [Abstract][Full Text] [Related]
15. Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
Liang Z; Wu M; Wang P; Quan H; Zhao J
PLoS One; 2023; 18(3):e0282603. PubMed ID: 36928727
[TBL] [Abstract][Full Text] [Related]
16. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase.
Hou N; Huo D
Breast Cancer Res Treat; 2013 Apr; 138(2):633-41. PubMed ID: 23446808
[TBL] [Abstract][Full Text] [Related]
17. Incidence trends in triple-negative breast cancer among women in the United States from 2010 to 2019 by race/ethnicity, age and tumor stage.
Du XL; Li Z
Am J Cancer Res; 2023; 13(2):678-691. PubMed ID: 36895969
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
Front Public Health; 2020; 8():576964. PubMed ID: 33415093
[TBL] [Abstract][Full Text] [Related]
19. Age distributions of breast cancer diagnosis and mortality by race and ethnicity in US women.
Hendrick RE; Monticciolo DL; Biggs KW; Malak SF
Cancer; 2021 Dec; 127(23):4384-4392. PubMed ID: 34427920
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States.
Du X
Mol Clin Oncol; 2022 Apr; 16(4):95. PubMed ID: 35368847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
